Role of interferons in diabetic retinopathy

doi:10.4239/wjd.v12.i7.939

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 7

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5681)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Tables (1-3) series.

Item

Count

PDF

423

WORD

137

HTML

3813

Tables (1-3)

250

Sum=4623

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

335

Download

723

Sum=1058

Jul 15, 2021 (publication date) through Jul 4, 2024

Times Cited of This Article

Times Cited (11)

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Diabetes. Jul 15, 2021; 12(7): 939-953
Published online Jul 15, 2021. doi: 10.4239/wjd.v12.i7.939

Table 3 Applications of interferon-α in ocular disorders

IFN	Clinical applications
IFN-α-2a	Ocular surface diseases: Tumors (such as limbal conjunctival melanoma, squamous neoplasias, and conjunctival MALT lymphoma)[134,137]; Mooren’s ulcers[138]; herpes simplex keratitis[139]
	Uveal disease: Behcet's uveitis[131]; serpiginous choroiditis[140]; choroidal neovascularization[141]; HHV-8-associated uveitis[142]; chronic noninfectious posterior uveitis[143]
	Macular and retinal disorders: Uveitic CME; angiogenesis after PRP; refractory non-infectious inflammatory macular edema[144]
IFN-α-2b	Ocular surface diseases: Tumors (such as squamous cell carcinoma[145], melanocytic tumors[145], CIN[146], conjunctival papillomatosis[147], and MALT lymphoma[57]); LSCD[135]; vernal keratoconjunctivitis[132]
	Uveal disease: Metastatic uveal melanoma[148]; Behcet's uveitis[149]
	Macular and retinal disorders: CME caused by intraocular infection[150]; refractory diabetic macular edema[133]
IFN-α-2	Dendritic keratitis[151]

MALT: Mucosa-associated lymphoid tissue; HHV-8: Human herpes virus 8; CME: Cystoid macular edema; PRP: Panretinal photocoagulation; CIN: Conjunctival and corneal intraepithelial neoplasia; LSCD: Limbal stem cell deficiency; IFN: Interferons.

Citation: Li BY, Tan W, Zou JL, He Y, Yoshida S, Jiang B, Zhou YD. Role of interferons in diabetic retinopathy. World J Diabetes 2021; 12(7): 939-953
URL: https://www.wjgnet.com/1948-9358/full/v12/i7/939.htm
DOI: https://dx.doi.org/10.4239/wjd.v12.i7.939